The rise in popularity of proton therapy is continuing across the globe.
It is estimated that more than 165,000 patients suffering from a variety of cancers, such as prostate cancer, brain tumors have already been successfully treated using this method. In fact, the proton therapy market is on track to become a multibillion-dollar industry by 2024.
The number of proton therapy center is increasing globally. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi-billion-dollar potential market.
The proton therapy market is likely to almost double by 2024 from its current market value. Globally, the numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are in Millions. The increased demand for proton therapy has motivated many prominent cancer centers in the world to provide proton therapy treatment.
The increased demand for proton therapy has motivated many prominent cancer centers in the world to provide proton therapy treatment. The number of proton therapy centers worldwide is anticipated to increase year on year, which in turn, will result in more clinical research, better clinician understanding and greater patient awareness of its benefits-which will help drive the further growth.
Galbiati Group is an Italian company, internationally-recognized for the quality of its machining, mechanical engineering and construction. Is active also in the medical sector with its high standard in quality.